Boston Trust Walden Corp Sells 337,657 Shares of Prestige Consumer Healthcare Inc. $PBH

Boston Trust Walden Corp reduced its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 55.4% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 272,292 shares of the company’s stock after selling 337,657 shares during the quarter. Boston Trust Walden Corp’s holdings in Prestige Consumer Healthcare were worth $12,490,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the business. Covestor Ltd grew its holdings in Prestige Consumer Healthcare by 45.6% in the 3rd quarter. Covestor Ltd now owns 1,589 shares of the company’s stock valued at $73,000 after buying an additional 498 shares during the period. Profund Advisors LLC increased its stake in shares of Prestige Consumer Healthcare by 356.2% during the 3rd quarter. Profund Advisors LLC now owns 33,690 shares of the company’s stock valued at $1,545,000 after acquiring an additional 26,305 shares during the last quarter. Vise Technologies Inc. acquired a new position in shares of Prestige Consumer Healthcare during the 3rd quarter valued at about $250,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Prestige Consumer Healthcare during the 3rd quarter worth about $216,000. Finally, Choreo LLC lifted its holdings in shares of Prestige Consumer Healthcare by 14.8% during the 3rd quarter. Choreo LLC now owns 20,376 shares of the company’s stock worth $935,000 after acquiring an additional 2,632 shares during the period. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on PBH shares. Weiss Ratings reissued a “sell (d+)” rating on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 22nd. Zacks Research downgraded shares of Prestige Consumer Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 29th. One analyst has rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $67.67.

Prestige Consumer Healthcare Trading Down 16.8%

PBH stock opened at $44.34 on Friday. The company has a market cap of $2.10 billion, a price-to-earnings ratio of 12.05, a PEG ratio of 1.67 and a beta of 0.30. The company has a quick ratio of 1.99, a current ratio of 3.23 and a debt-to-equity ratio of 1.06. The business has a fifty day simple moving average of $48.34 and a 200-day simple moving average of $53.88. Prestige Consumer Healthcare Inc. has a 52 week low of $42.62 and a 52 week high of $71.07.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, November 5th. The company reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.06. Prestige Consumer Healthcare had a return on equity of 11.39% and a net margin of 15.57%. The business had revenue of $336.31 million for the quarter, compared to analyst estimates of $329.14 million. During the same period last year, the company posted $1.07 EPS. The business’s quarterly revenue was up 22.7% on a year-over-year basis. On average, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.56 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc (NYSE: PBH) is a consumer healthcare company that develops, acquires, markets and distributes over-the-counter health and wellness products. Its portfolio is focused on established brands designed to address everyday healthcare needs, including digestive health, eye and ear care, oral care, pain relief, cold and allergy symptoms, feminine care and dermatological conditions.

The company’s brands include Dramamine and Bonine for motion-sickness relief; BC and Goody’s for pain relief; Clear Eyes and Murine for eye and ear care; Chloraseptic for sore-throat relief; Compound W for wart removal; Fleet for gastrointestinal health; and Summer’s Eve for feminine care.